A Randomized, Double-Blind, Multiple Dose, Placebo-Controlled, Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of RO4995819 Following Oral Administration in Healthy Elderly Subjects
Phase of Trial: Phase I
Latest Information Update: 10 Jun 2016
At a glance
- Drugs Decoglurant (Primary)
- Indications Depressive disorders
- Focus Adverse reactions
- Sponsors Roche
- 23 May 2013 Actual end date changed from Apr 2012 to Dec 2011 as reported by ClinicalTrials.gov.
- 21 May 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
- 16 Mar 2012 Actual patient number changed from 15 to 30 as reported by ClinicalTrials.gov.